Subtype
Malignant Hepatobiliary Neoplasm
CI-CAN-00001136Explore in graph →
1,160 active trials17 approved drugs42 evidence items
- NCIt
- C8609
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001136Explore in graph →
Clinical trials
5,029 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (561)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05781958 | Cadonilimab Combined With Gem/Cis as First Line Therapy in Patients With Advanced ICC | unknown | Phase 2 | 64 | Shen FengOTHER | 1 | Nov 2, 2023 | clinicaltrials |
| NCT06111326 | BC3402 in Combination With Durvalumab in Patients With Advanced Hepatocellular Carcinoma | unknown | Phase 1 / Phase 2 | 83 | Biocity Biopharmaceutics Co., Ltd.INDUSTRY | 1 | Nov 1, 2023 | clinicaltrials |
| NCT06106750 |
| Endoscopic Scissors Cutting Nasobiliary Duct VS Bilateral Plastic Stent |
| unknown |
| N/A |
| 122 |
| First People's Hospital of HangzhouOTHER |
| 1 |
| Oct 30, 2023 |
| clinicaltrials |
| NCT06101758 | Ultrasound Assessment of Sarcopenia in Patients With Chronic Liver Disease: the SARCOLIVER Study(SARCOLIVER) | unknown | N/A | 125 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Oct 26, 2023 | clinicaltrials |
| NCT06003673 | A Clinical Study of Tislelizumab Combined With TACE and Lenvatinib in the Neoadjuvant Treatment of Resectable HCC | unknown | Phase 4 | 20 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | Oct 24, 2023 | clinicaltrials |
| NCT06088459 | NWRD06 DNA Plasmid for HCC After Radical Resection | unknown | Phase 1 | 9 | Newish Technology (Beijing) Co., Ltd.INDUSTRY | 1 | Oct 18, 2023 | clinicaltrials |
| NCT05250843 | TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC | unknown | Phase 2 / Phase 3 | 90 | Third Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Oct 13, 2023 | clinicaltrials |
| NCT06081322 | A Study to Evaluate the Safety and Efficacy of PRRT With 177Lu-EB-FAPI in Patients With Advanced Cholopancreatic Tumors(CISPD-5) | unknown | Phase 1 | 29 | Zhejiang UniversityOTHER | 1 | Oct 13, 2023 | clinicaltrials |
| NCT06065592 | Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms(CAT_PB) | unknown | Phase 1 | 500 | Lebanese UniversityOTHER | 1 | Oct 6, 2023 | clinicaltrials |
| NCT06070623 | Follow up After TACE by Elastography and Color Doppler. | unknown | — | 54 | Assiut UniversityOTHER | 0 | Oct 6, 2023 | clinicaltrials |
| NCT06042842 | The Value of circRNAs (hsa_circ_0004001) in Early Diagnosis of HCC | unknown | — | 102 | Assiut UniversityOTHER | 0 | Oct 4, 2023 | clinicaltrials |
| NCT06062706 | Robotic vs. Laparoscopic vs. Open Living Donor Hepatectomy | unknown | — | 3,448 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Oct 2, 2023 | clinicaltrials |
| NCT06061744 | Robot-assisted vs Laparoscopic vs Open Radical Cholecystectomy for Gallbladder Cancer | unknown | — | 600 | Hospital del MarOTHER | 1 | Sep 29, 2023 | clinicaltrials |
| NCT04033107 | High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors | unknown | Phase 2 | 30 | Zhongnan HospitalOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT05352646 | NewishT Cell Therapy for HCC With High Risk of Recurrence After Radical Resection | unknown | Phase 1 | 26 | Newish Technology (Beijing) Co., Ltd.INDUSTRY | 1 | Sep 28, 2023 | clinicaltrials |
| NCT05926336 | The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of Action | unknown | Phase 4 | 1,316 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT06048289 | Prospective Observational Study to Predict the Response of Biliary Tract Tumors to Immunotherapy | unknown | — | 150 | Zhejiang Cancer HospitalOTHER | 1 | Sep 25, 2023 | clinicaltrials |
| NCT05010434 | Sintilimab and Bevacizumab Combined With Radiotherapy for Advanced Hepatocellular Carcinoma | unknown | Phase 2 | 46 | Sun Yat-sen UniversityOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT06006338 | 3D Printed Models for Liver Surgery | unknown | Phase 1 | 5 | Zhejiang Cancer HospitalOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT06047990 | Endobiliary Percutaneous Cryobiopsy in Malignant Biliary Obstruction(BICRYOB) | unknown | N/A | 20 | Brno University HospitalOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT06013943 | Envafolimab Combined With GEMOX in First-line Treatment of Advanced GBC | unknown | Phase 2 | 30 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Sep 15, 2023 | clinicaltrials |
| NCT06039280 | Comparison of Dexamethasone and N Acetylcysteine (NAC) Versus N Acetylcysteine (NAC) Alone in the Prevention of Post Embolization Syndrome in Patients With Hepatocellular Carcinoma Following Transarterial Chemoembolization. | unknown | N/A | 150 | Institute of Liver and Biliary Sciences, IndiaOTHER | 1 | Sep 15, 2023 | clinicaltrials |
| NCT05992584 | Lenvatinib, Sintilimab Plus SIRT for Unresectable HCC | unknown | Phase 2 | 30 | Second Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Sep 14, 2023 | clinicaltrials |
| NCT06001567 | Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAIC | unknown | Phase 2 | 30 | Second Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Sep 14, 2023 | clinicaltrials |
| NCT03447951 | A Study of PTS100 in Primary HCC Patients(OASES) | unknown | Phase 2 | 33 | Gongwin Biopharm Co., Ltd.INDUSTRY | 1 | Sep 13, 2023 | clinicaltrials |
| NCT05371873 | A Study of Chromosomal Abnormalities as a Predictor of Staging and Prognosis in Patients With Liver Cancer | unknown | — | 250 | First Affiliated Hospital of Zhejiang UniversityOTHER | 1 | Sep 13, 2023 | clinicaltrials |
| NCT05443217 | Relationship Between Microbiota and Prognosis of Hepatocellular Carcinoma(HCC) After Systemic Treatments | unknown | — | 200 | First Affiliated Hospital of Wenzhou Medical UniversityOTHER | 1 | Sep 13, 2023 | clinicaltrials |
| NCT05443230 | Effect of Sarcopenia on HCC After Lenvatinib and Anti-PD-1 Treatment | unknown | — | 200 | First Affiliated Hospital of Wenzhou Medical UniversityOTHER | 1 | Sep 13, 2023 | clinicaltrials |
| NCT05448222 | Effect of Sarcopenia on Hepatocellular Carcinoma(HCC) After Systemic Therapies | unknown | — | 300 | First Affiliated Hospital of Wenzhou Medical UniversityOTHER | 1 | Sep 13, 2023 | clinicaltrials |
| NCT05812430 | Anlotinib Plus TQB2450 Combined With Nab-paclitaxel and Cisplatin as First-line Treatment for Advanced Biliary Tract Cancer | unknown | Phase 2 | 20 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | Sep 13, 2023 | clinicaltrials |
| NCT06034977 | Phase 2 Study of ADI-PEG 20 Plus Lenvatinib Treatment in Subjects With Unresectable Hepatocellular Carcinoma | unknown | Phase 2 | 120 | Chang Gung Memorial HospitalOTHER | 1 | Sep 13, 2023 | clinicaltrials |
| NCT06031480 | Anlotinib and TQB2450 in Advanced Hepatocellular Carcinoma After Failure of Prior Immune Checkpoint Inhibitors(FAITH) | unknown | Phase 2 | 55 | Shanghai Zhongshan HospitalOTHER | 1 | Sep 11, 2023 | clinicaltrials |
| NCT06029829 | The Clinical Significance of Peripheral Blood T Lymphocyte PD-1 Expression and T Cell Subset Distribution. | unknown | Phase 2 | 60 | Xin-Hua XuOTHER | 1 | Sep 8, 2023 | clinicaltrials |
| NCT06023147 | A Real-world Study of the Short-term Efficacy and Safety of E-TACE in Patients With Hepatocellular Carcinoma (HCC) | unknown | N/A | 298 | Xuhua DuanOTHER | 1 | Sep 7, 2023 | clinicaltrials |
| NCT04852211 | Laparoscopic Versus Open Major Hepatectomy for HCC Hepatectomy for Hepatocellular Carcinoma(AP-LAPO) | unknown | N/A | 212 | Chinese University of Hong KongOTHER | 1 | Aug 31, 2023 | clinicaltrials |
| NCT05394246 | Fluorescent-labeled IgG for Liver Tumor Detection | unknown | N/A | 60 | Chinese Academy of SciencesOTHER_GOV | 1 | Aug 30, 2023 | clinicaltrials |
| NCT05681949 | Therapeutic Assistance and Decision-making Algorithms in Hepatobiliary Tumor Boards(ADBoard) | unknown | N/A | 1,200 | Charite University, Berlin, GermanyOTHER | 1 | Aug 24, 2023 | clinicaltrials |
| NCT03731923 | Abbreviated MRI for HCC Surveillance | unknown | N/A | 257 | Seoul National University HospitalOTHER | 1 | Aug 18, 2023 | clinicaltrials |
| NCT05996666 | Primary Liver Cancer Early Detection(PRIMe-liver) | unknown | — | 701 | The First Hospital of Jilin UniversityOTHER | 1 | Aug 18, 2023 | clinicaltrials |
| NCT04135690 | HAIC Plus Toripalimab vs. HAIC Plus Sorafenib for HCC With PVTT: a Non-comparative, Prospective, Randomized Trial | unknown | Phase 2 | 60 | Sun Yat-sen UniversityOTHER | 1 | Aug 15, 2023 | clinicaltrials |
| NCT05023109 | GP Chemotherapy in Combination With Anti-PD-1 and Anti-TIGIT in Unresectable Advanced BTC | unknown | Phase 2 | 45 | Shanghai Zhongshan HospitalOTHER | 1 | Aug 15, 2023 | clinicaltrials |
| NCT05156788 | Tislelizumab（Anti PD-1), Lenvatinib and GEMOX Transformation in the Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer | unknown | Phase 2 | 40 | Shanghai Zhongshan HospitalOTHER | 1 | Aug 15, 2023 | clinicaltrials |
| NCT05233293 | Spyglass+RFA Versus Cytobrush+RFA for Extrahepatic Cholangiocarcinoma | unknown | N/A | 200 | First People's Hospital of HangzhouOTHER | 1 | Aug 15, 2023 | clinicaltrials |
| NCT05986383 | Multi-center Clinical Study on the Decision Tree of Precision Hepatectomy in China Precision Hepatectomy Decision Tree | unknown | — | 820 | Beijing Tsinghua Chang Gung HospitalOTHER | 0 | Aug 14, 2023 | clinicaltrials |
| NCT05987514 | Multimodal Ultrasound and Hepatocellular Response to Local Treatments | unknown | N/A | 50 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Aug 14, 2023 | clinicaltrials |
| NCT05981066 | A Clinical Study of mRNA Vaccine (ABOR2014/IPM511) in Patients With Advanced Hepatocellular Carcinoma | unknown | N/A | 48 | Peking Union Medical College HospitalOTHER | 1 | Aug 8, 2023 | clinicaltrials |
| NCT05970159 | Impact of Preoperative Serum Albumin Level on Postoperative Outcomes in Chinese HCC Patients Treated With Surgery(REAL) | unknown | — | 480 | Shanghai Zhongshan HospitalOTHER | 1 | Aug 3, 2023 | clinicaltrials |
| NCT04680598 | Comparison of HBV Reactivation Between Patients With High HBV-DNA and Low HBV-DNA Loads Undergoing ICI and Concurrent Antiviral Prophylaxis: a Prospective Observational Study | unknown | — | 800 | Sun Yat-sen UniversityOTHER | 1 | Aug 2, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Nov 2, 2023source: clinicaltrials